Skip to main content

Table 1 Participant characteristics at EDIC baseline by quartile of women’s initial AMH measurement (n = 390 women)

From: Anti-Müllerian hormone and its relationships with subclinical cardiovascular disease and renal disease in a longitudinal cohort study of women with type 1 diabetes

Range of AMH (ng/dl)

Quartile 1

Quartile 2

Quartile 3

Quartile 4

p-value

<0.96

0.96–2.70

2.70–4.61

>4.61

n = 99

n = 97

n = 98

n = 97

Age (years)

40.6 ± 6.2

34.6 ± 6.5

32.6 ± 6.0

31.0 ± 5.6

<0.0001

Diabetes duration (years)

14.4 ± 5.0

13.9 ± 5.2

14.4 ± 5.5

13.8 ± 5.4

0.78

Current smoking (%)

26.6%

20.4%

14.7%

15.1%

0.13

Current oral contraceptive use (%)

9.6%

18.3%

17.9%

11.8%

0.23

Body mass index (kg/m2)

26.8 ± 4.7

25.1 ± 3.8

25.8 ± 3.9

25.7 ± 3.8

0.05

Waist circumference (cm)

80.9 ± 11.2

77.2 ± 7.6

77.4 ± 8.6

78.7 ± 8.8

0.02

Systolic blood pressure (mm Hg)

118.4 ± 13.0

113.2 ± 10.8

112.4 ± 11.2

111.7 ± 12.1

0.0005

Diastolic blood pressure (mm Hg)

73.9 ± 8.9

72.8 ± 9.0

71.5 ± 8.4

72.0 ± 9.9

0.27

Hypertensiona

10.6%

7.5%

10.5%

14.0%

0.57

Total cholesterol (mg/dl)

200.5 ± 37.6

174.4 ± 31.0

179.3 ± 30.7

189.1 ± 33.1

<0.0001

Low-density lipoprotein cholesterol (mg/dl)

123.5 ± 34.8

101.8 ± 26.2

106.1 ± 26.8

113.1 ± 26.7

<0.0001

High-density lipoprotein cholesterol (mg/dl)

59.6 ± 14.5

59.6 ± 13.6

59.7 ± 13.8

59.8 ± 14.7

0.99

Triglycerides (mg/dl)

86.5 ± 45.0

65.1 ± 28.1

66.9 ± 30.5

80.6 ± 43.4

0.0001

Lipid medication use (%)

1.1%

2.2%

0%

0%

0.29

Log albumin excretion ratio (mg/day)

2.3 ± 1.0

2.5 ± 1.1

2.2 ± 1.0

2.6 ± 1.1

0.02

Estimated glomerular filtration rate (mL/min/1.73 m2)

106.2 ± 11.9

114.4 ± 16.2

113.3 ± 12.5

116.7 ± 13.3

<0.0001

  1. aHypertension defined as systolic blood pressure ≥ 140 OR diastolic blood pressure ≥ 90 OR anti-hypertensive medication use
  2. Means ± standard deviations or percentages shown